Literature DB >> 31278586

A New Way Forward in the Emergency Department.

Evan S Schwarz1, JoAn R Laes2, Timothy J Wiegand3.   

Abstract

Keywords:  Addiction; Buprenorphine; Emergency department; Medication-assisted treatment

Year:  2019        PMID: 31278586      PMCID: PMC6825116          DOI: 10.1007/s13181-019-00718-x

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


× No keyword cloud information.
  21 in total

1.  Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004-2013.

Authors:  Brendan Saloner; Shankar Karthikeyan
Journal:  JAMA       Date:  2015-10-13       Impact factor: 56.272

2.  The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.

Authors:  J E Hood; C N Behrends; A Irwin; B R Schackman; D Chan; K Hartfield; J Hess; C Banta-Green; L Whiteside; B Finegood; J Duchin
Journal:  Int J Drug Policy       Date:  2019-02-23

3.  Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.

Authors:  Gail D'Onofrio; Marek C Chawarski; Patrick G O'Connor; Michael V Pantalon; Susan H Busch; Patricia H Owens; Kathryn Hawk; Steven L Bernstein; David A Fiellin
Journal:  J Gen Intern Med       Date:  2017-02-13       Impact factor: 5.128

4.  ACMT and AACT position statement: preventing occupational fentanyl and fentanyl analog exposure to emergency responders.

Authors:  Michael J Moss; Brandon J Warrick; Lewis S Nelson; Charles A McKay; Pierre-André Dubé; Sophie Gosselin; Robert B Palmer; Andrew I Stolbach
Journal:  Clin Toxicol (Phila)       Date:  2017-09-05       Impact factor: 4.467

5.  The Surviving Sepsis Campaign Bundle: 2018 Update.

Authors:  Mitchell M Levy; Laura E Evans; Andrew Rhodes
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

6.  Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations.

Authors:  Sharon Stancliff; Herman Joseph; Chunki Fong; Terry Furst; Sandra D Comer; Perrine Roux
Journal:  J Addict Dis       Date:  2012

7.  Buprenorphine prescription by general practitioners in a French region.

Authors:  X Thirion; V Lapierre; J Micallef; E Ronflé; A Masut; V Pradel; C Coudert; J C Mabriez; J L Sanmarco
Journal:  Drug Alcohol Depend       Date:  2002-01-01       Impact factor: 4.492

8.  Understanding the use of diverted buprenorphine.

Authors:  Theodore J Cicero; Matthew S Ellis; Howard D Chilcoat
Journal:  Drug Alcohol Depend       Date:  2018-10-12       Impact factor: 4.492

9.  Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.

Authors:  Elenore Patterson Bhatraju; Ellie Grossman; Babak Tofighi; Jennifer McNeely; Danae DiRocco; Mara Flannery; Ann Garment; Keith Goldfeld; Marc N Gourevitch; Joshua D Lee
Journal:  Addict Sci Clin Pract       Date:  2017-02-28

10.  Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI.

Authors:  Ataollah Doost Hosseiny; Soniah Moloi; Jaya Chandrasekhar; Ahmad Farshid
Journal:  Open Heart       Date:  2016-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.